30837-00-4Relevant academic research and scientific papers
Discovery of a novel series of N-phenylindoline-5-sulfonamide derivatives as potent, selective, and orally bioavailable Acyl CoA:monoacylglycerol acyltransferase-2 inhibitors
Sato, Kenjiro,Takahagi, Hiroki,Yoshikawa, Takeshi,Morimoto, Shinji,Takai, Takafumi,Hidaka, Kousuke,Kamaura, Masahiro,Kubo, Osamu,Adachi, Ryutaro,Ishii, Tsuyoshi,Maki, Toshiyuki,Mochida, Taisuke,Takekawa, Shiro,Nakakariya, Masanori,Amano, Nobuyuki,Kitazaki, Tomoyuki
, p. 3892 - 3909 (2015)
Acyl CoA:monoacylglycerol acyltransferase-2 (MGAT2) has attracted interest as a novel target for the treatment of obesity and metabolic diseases. Starting from N-phenylbenzenesulfonamide derivative 1 with moderate potency for MGAT2 inhibition, we explored
